161 related articles for article (PubMed ID: 29759564)
1. Biological aspects of chondrosarcoma: Leaps and hurdles.
Mery B; Espenel S; Guy JB; Rancoule C; Vallard A; Aloy MT; Rodriguez-Lafrasse C; Magné N
Crit Rev Oncol Hematol; 2018 Jun; 126():32-36. PubMed ID: 29759564
[TBL] [Abstract][Full Text] [Related]
2. Novel therapeutic approaches in chondrosarcoma.
Polychronidou G; Karavasilis V; Pollack SM; Huang PH; Lee A; Jones RL
Future Oncol; 2017 Mar; 13(7):637-648. PubMed ID: 28133974
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin promotes VEGF-A-dependent angiogenesis in human chondrosarcoma through PI3K, Akt, mTOR, and HIF-α pathway.
Lee HP; Lin CY; Shih JS; Fong YC; Wang SW; Li TM; Tang CH
Oncotarget; 2015 Nov; 6(34):36746-61. PubMed ID: 26468982
[TBL] [Abstract][Full Text] [Related]
4. SDF-1/CXCR4 signaling up-regulates survivin to regulate human sacral chondrosarcoma cell cycle and epithelial-mesenchymal transition via ERK and PI3K/AKT pathway.
Yang P; Wang G; Huo H; Li Q; Zhao Y; Liu Y
Med Oncol; 2015 Jan; 32(1):377. PubMed ID: 25428386
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 promotes MMP-13 production and migration in human chondrosarcoma cells through FAK/PI3K/Akt/mTOR pathways.
Wu MH; Lo JF; Kuo CH; Lin JA; Lin YM; Chen LM; Tsai FJ; Tsai CH; Huang CY; Tang CH
J Cell Physiol; 2012 Aug; 227(8):3016-26. PubMed ID: 21959927
[TBL] [Abstract][Full Text] [Related]
6. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
7. An update on current and future treatment options for chondrosarcoma.
MacDonald IJ; Lin CY; Kuo SJ; Su CM; Tang CH
Expert Rev Anticancer Ther; 2019 Sep; 19(9):773-786. PubMed ID: 31462102
[No Abstract] [Full Text] [Related]
8. Oncogenic and Therapeutic Targeting of PTEN Loss in Bone Malignancies.
Xi Y; Chen Y
J Cell Biochem; 2015 Sep; 116(9):1837-47. PubMed ID: 25773992
[TBL] [Abstract][Full Text] [Related]
9. Chondrosarcoma: A Rare Misfortune in Aging Human Cartilage? The Role of Stem and Progenitor Cells in Proliferation, Malignant Degeneration and Therapeutic Resistance.
Boehme KA; Schleicher SB; Traub F; Rolauffs B
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361725
[TBL] [Abstract][Full Text] [Related]
10. Endometrial Carcinoma: Specific Targeted Pathways.
Eritja N; Yeramian A; Chen BJ; Llobet-Navas D; Ortega E; Colas E; Abal M; Dolcet X; Reventos J; Matias-Guiu X
Adv Exp Med Biol; 2017; 943():149-207. PubMed ID: 27910068
[TBL] [Abstract][Full Text] [Related]
11. miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis.
Sun X; Charbonneau C; Wei L; Chen Q; Terek RM
Mol Cancer Res; 2015 Sep; 13(9):1347-57. PubMed ID: 26013170
[TBL] [Abstract][Full Text] [Related]
12. Targeting autophagy to overcome drug resistance in cancer therapy.
Kumar A; Singh UK; Chaudhary A
Future Med Chem; 2015 Aug; 7(12):1535-42. PubMed ID: 26334206
[TBL] [Abstract][Full Text] [Related]
13. Visfatin-Induced Inhibition of miR-1264 Facilitates PDGF-C Synthesis in Chondrosarcoma Cells and Enhances Endothelial Progenitor Cell Angiogenesis.
Song CY; Chang SL; Lin CY; Tsai CH; Yang SY; Fong YC; Huang YW; Wang SW; Chen WC; Tang CH
Cells; 2022 Nov; 11(21):. PubMed ID: 36359873
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways.
McCubrey JA; Steelman LS; Kempf CR; Chappell WH; Abrams SL; Stivala F; Malaponte G; Nicoletti F; Libra M; Bäsecke J; Maksimovic-Ivanic D; Mijatovic S; Montalto G; Cervello M; Cocco L; Martelli AM
J Cell Physiol; 2011 Nov; 226(11):2762-81. PubMed ID: 21302297
[TBL] [Abstract][Full Text] [Related]
15. IGF-I enhances α5β1 integrin expression and cell motility in human chondrosarcoma cells.
Wu CM; Li TM; Hsu SF; Su YC; Kao ST; Fong YC; Tang CH
J Cell Physiol; 2011 Dec; 226(12):3270-7. PubMed ID: 21344385
[TBL] [Abstract][Full Text] [Related]
16. Gab1 regulates SDF-1-induced progression via inhibition of apoptosis pathway induced by PI3K/AKT/Bcl-2/BAX pathway in human chondrosarcoma.
Fan Y; Yang F; Cao X; Chen C; Zhang X; Zhang X; Lin W; Wang X; Liang C
Tumour Biol; 2016 Jan; 37(1):1141-9. PubMed ID: 26276357
[TBL] [Abstract][Full Text] [Related]
17. Update on targets and novel treatment options for high-grade osteosarcoma and chondrosarcoma.
van Oosterwijk JG; Anninga JK; Gelderblom H; Cleton-Jansen AM; Bovée JV
Hematol Oncol Clin North Am; 2013 Oct; 27(5):1021-48. PubMed ID: 24093174
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.
Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K
Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788
[TBL] [Abstract][Full Text] [Related]
19. Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy.
Riquelme I; Saavedra K; Espinoza JA; Weber H; García P; Nervi B; Garrido M; Corvalán AH; Roa JC; Bizama C
Oncotarget; 2015 Sep; 6(28):24750-79. PubMed ID: 26267324
[TBL] [Abstract][Full Text] [Related]
20. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.
Polivka J; Janku F
Pharmacol Ther; 2014 May; 142(2):164-75. PubMed ID: 24333502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
